Bellevue Life Sciences Acquisition CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OSR Health, Inc. has announced its 2026 Annual Meeting of Stockholders to be held virtually on August 7, 2026, proposing the re-election of directors, ratification of auditors, an advisory vote on executive compensation, and a significant increase in authorized shares.
OSR Holdings, Inc. is holding its annual meeting on June 18, 2026, to elect directors, ratify auditors, approve executive compensation, amend its omnibus incentive plan, and change its corporate name to OSR Health, Inc.
OSR Holdings, Inc. is seeking shareholder approval for the election of seven directors, an advisory vote on executive compensation, the adoption of new equity incentive plans, and a significant common share issuance that could exceed 20% of outstanding stock, potentially leading to dilution.
Bellevue Life Sciences Acquisition Corp. is seeking stockholder approval to extend the deadline for completing a business combination and to remove a net tangible asset requirement from its charter.
Bellevue Life Sciences Acquisition Corp. is seeking stockholder approval to extend the deadline for completing a business combination from May 14, 2024, to November 14, 2024.